SCHEMBL21499341

SCHEMBL21499341

CC/C=C/CCCCC/C=C/CCCCCCCC(=O)N1CCCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
ATM Q13315 1/20 0.53
ALDH1A1 P00352 3/20 0.50
F7 P08709 2/20 0.50
F3 P13726 2/20 0.50
MAPT P10636 2/20 0.50
CYP19A1 P11511 2/20 0.50
OXER1 Q8TDS5 1/20 0.50
KDM4E B2RXH2 1/20 0.50
FFAR1 O14842 1/20 0.50
NR1I2 O75469 1/20 0.50
LMNA P02545 1/20 0.50
PLA2G1B P04054 1/20 0.50
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
PTGS1 P23219 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19060656 1.00 L3MBTL1 (0.62) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL21499397 0.95 ALDH1A1 (0.58) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL19051851 0.95 ALDH1A1 (0.58) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL28188747 0.90 L3MBTL1 (0.77) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL20215371 0.90 L3MBTL1 (0.77) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL4242272 0.90 L3MBTL1 (0.77) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL11545687 0.90 L3MBTL1 (0.77) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL11545683 0.90 L3MBTL1 (0.77) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL7065130 0.89 L3MBTL1 (0.77) L3MBTL1MEN1KMT2ATDP1ATM
SCHEMBL7065131 0.89 L3MBTL1 (0.77) L3MBTL1MEN1KMT2ATDP1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450271-B2 Compounds for inhibition of fungal toxin production BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450271-B2 Compounds for inhibition of fungal toxin production ERG28, CYP51A1, ETF1 L3MBTL1 2416/4885MEN1 325/4885KMT2A 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.